Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


New Amedeo service:

Amedeo COVID-19 (formerly 2019-nCoV)

Weekly publication summary


  Anemia

  Free Subscription


Articles published in Am J Hematol

Retrieve available abstracts of 207 articles:
HTML format
Text format



Single Articles


    February 2020
  1. TOLU S, Reyes-Gil M, Ogu UO, Thomas M, et al
    Inherited High Fetal Hemoglobin in Sickle Cell Anemia: Outcomes with Aging High HbF and Sickle Cell.
    Am J Hematol. 2020 Feb 18. doi: 10.1002/ajh.25759.
    PubMed     Text format    


  2. SCHECKEL CJ, Yanardag Acik D, Ravindran A, Marshall A, et al
    Hapticophagia: Tactile chew cravings in iron deficiency anemia.
    Am J Hematol. 2020 Feb 5. doi: 10.1002/ajh.25749.
    PubMed     Text format    


    January 2020
  3. STEINBERG MH
    Treating Sickle Cell Anemia: A New Era Dawns.
    Am J Hematol. 2020 Jan 10. doi: 10.1002/ajh.25724.
    PubMed     Text format    


  4. WILLEN SM, McNeil JB, Rodeghier M, Kerchberger VE, et al
    Haptoglobin genotype predicts severe acute vaso-occlusive pain episodes in children with sickle cell anemia.
    Am J Hematol. 2020 Jan 9. doi: 10.1002/ajh.25728.
    PubMed     Text format    


    December 2019
  5. TRUDEL G, Shafer J, Laneuville O, Ramsay T, et al
    Characterizing the effect of exposure to microgravity on anemia, more space is worse.
    Am J Hematol. 2019 Dec 9. doi: 10.1002/ajh.25699.
    PubMed     Text format     Abstract available


  6. KAKO S, Kanda Y, Onizuka M, Aotsuka N, et al
    Allogeneic hematopoietic stem cell transplantation for aplastic anemia with pre-transplant conditioning using fludarabine, reduced-dose cyclophosphamide, and low-dose thymoglobulin: a KSGCT prospective study.
    Am J Hematol. 2019 Dec 5. doi: 10.1002/ajh.25693.
    PubMed     Text format     Abstract available


    August 2019
  7. GALADANCI AA, Galadanci NA, Jibir BW, Abdullahi SU, et al
    Approximately 40,000 children with sickle cell anemia require screening with TCD and treating with hydroxyurea for stroke prevention in three states in northern Nigeria.
    Am J Hematol. 2019 Aug 18. doi: 10.1002/ajh.25616.
    PubMed     Text format     Abstract available


  8. PATEL R, Kang S, Valeshabad AK, Shah BN, et al
    Kidney Ultrasound Findings According to Kidney Function in Sickle Cell Anemia.
    Am J Hematol. 2019 Aug 4. doi: 10.1002/ajh.25602.
    PubMed     Text format    


    July 2019
  9. KAWATA E, Chin-Yee I, Hsia C, Solh Z, et al
    IgA-mediated autoimmune hemolytic anemia.
    Am J Hematol. 2019 Jul 21. doi: 10.1002/ajh.25581.
    PubMed     Text format    


  10. SOYOUNG CHOI BA, O'Neil SH, Joshi AA, Li J, et al
    Anemia Predicts Lower White Matter Volume and Cognitive Performance in Sickle and Non-Sickle Cell Anemia Syndrome.
    Am J Hematol. 2019 Jul 1. doi: 10.1002/ajh.25570.
    PubMed     Text format     Abstract available


    June 2019
  11. AUERBACH M, Henry D, Derman RJ, Achebe MM, et al
    A prospective, multicenter, randomized comparison of iron isomaltoside 1000 versus iron sucrose in patients with iron deficiency anemia (the FERWON-IDA trial).
    Am J Hematol. 2019 Jun 26. doi: 10.1002/ajh.25564.
    PubMed     Text format     Abstract available


  12. FATTIZZO B, Cavallaro F, Milesi G, Barcellini W, et al
    Iron mobilization in a real life cohort of aplastic anemia patients treated with eltrombopag.
    Am J Hematol. 2019 Jun 6. doi: 10.1002/ajh.25550.
    PubMed     Text format    


  13. DETTERICH JA, Kato R, Bush A, Chalacheva P, et al
    Sickle cell microvascular paradox-oxygen supply-demand mismatch.
    Am J Hematol. 2019;94:678-688.
    PubMed     Text format     Abstract available


  14. DUTTA D, Methe BA, Morris A, Lim SH, et al
    Effects of rifaximin on circulating aged neutrophils in sickle cell disease.
    Am J Hematol. 2019;94:E175-E176.
    PubMed     Text format    


  15. NANKANJA R, Kadhumbula S, Tagoola A, Geisberg M, et al
    HemoTypeSC Demonstrates >99% Field Accuracy in a Sickle Cell Disease Screening Initiative in Children of Southeastern Uganda.
    Am J Hematol. 2019;94:E164-E166.
    PubMed     Text format    


  16. DUTTA D, Methe B, Morris A, Lim SH, et al
    Elevated urinary 3-indoxyl sulfate in sickle cell disease.
    Am J Hematol. 2019;94:E162-E164.
    PubMed     Text format    


  17. ITZEP NP, Jadhav SP, Kanne CK, Sheehan VA, et al
    Spontaneous healing of avascular necrosis of the femoral head in sickle cell disease.
    Am J Hematol. 2019;94:E160-E162.
    PubMed     Text format    


    May 2019
  18. MCGANN PT, Niss O, Dong M, Marahatta A, et al
    Robust Clinical and Laboratory Response to Hydroxyurea Using Pharmacokinetically Guided Dosing for Young Children with Sickle Cell Anemia.
    Am J Hematol. 2019 May 20. doi: 10.1002/ajh.25510.
    PubMed     Text format     Abstract available


  19. RAJAGOPAL R, Bennett R, Liang J, Royle G, et al
    High dose carfilzomib proteasome inhibition induces anemia by oxidative hemolysis: A case series of 8 patients from a single centre.
    Am J Hematol. 2019 May 7. doi: 10.1002/ajh.25504.
    PubMed     Text format    


  20. RAB MAE, van Oirschot BA, Bos J, Merkx TH, et al
    Rapid and reproducible characterization of sickling during automated deoxygenation in sickle cell disease patients.
    Am J Hematol. 2019;94:575-584.
    PubMed     Text format     Abstract available


  21. VINER M, Zhou J, Allison D, Han J, et al
    The morbidity and mortality of end stage renal disease in sickle cell disease.
    Am J Hematol. 2019;94:E138-E141.
    PubMed     Text format    


  22. WALKER AL, Gaydos LM, Farzan R, De Castro L, et al
    Social media discussions provide new insight about perceptions of hydroxyurea in the sickle cell community.
    Am J Hematol. 2019;94:E134-E136.
    PubMed     Text format    


  23. WEISS M, Parisi Jun M, Sheth S
    Clinical and economic burden of regularly transfused adult patients with beta-thalassemia in the United States: A retrospective cohort study using payer claims.
    Am J Hematol. 2019;94:E129-E132.
    PubMed     Text format    


  24. HOFFMAN JF
    Erythrocyte ATP, a possible therapeutic approach for sickle cell disease.
    Am J Hematol. 2019;94:E117.
    PubMed     Text format    


  25. BAO EL, Lareau CA, Brugnara C, Fulcher IR, et al
    Heritability of fetal hemoglobin, white cell count, and other clinical traits from a sickle cell disease family cohort.
    Am J Hematol. 2019;94:522-527.
    PubMed     Text format     Abstract available


    April 2019
  26. CHAI Y, Bush AM, Coloigner J, Nederveen AJ, et al
    White matter has impaired resting oxygen delivery in sickle cell patients.
    Am J Hematol. 2019;94:467-474.
    PubMed     Text format     Abstract available


  27. KIM TO, Grimes AB, Kirk S, Arulselvan A, et al
    Association of a positive direct antiglobulin test with chronic immune thrombocytopenia and use of second line therapies in children: A multi-institutional review.
    Am J Hematol. 2019;94:461-466.
    PubMed     Text format     Abstract available


  28. TAHER AT, Origa R, Perrotta S, Kouraklis A, et al
    Influence of patient-reported outcomes on the treatment effect of deferasirox film-coated and dispersible tablet formulations in the ECLIPSE trial: A post hoc mediation analysis.
    Am J Hematol. 2019;94:E96-E99.
    PubMed     Text format    


  29. OYEDEJI C, Strouse JJ, Crawford RD, Garrett ME, et al
    A multi-institutional comparison of younger and older adults with sickle cell disease.
    Am J Hematol. 2019;94:E115-E117.
    PubMed     Text format    


  30. LEBENSBURGER JD, Aban I, Pernell B, Kasztan M, et al
    Hyperfiltration during early childhood precedes albuminuria in pediatric sickle cell nephropathy.
    Am J Hematol. 2019;94:417-423.
    PubMed     Text format     Abstract available


  31. ALLY M, Magesa P, Luzzatto L
    High frequency of acquired aplastic anemia in Tanzania.
    Am J Hematol. 2019;94:E86-E88.
    PubMed     Text format    


  32. REES C, Lund K, Bain BJ
    Infantile pyknocytosis.
    Am J Hematol. 2019;94:489-490.
    PubMed     Text format    


    March 2019
  33. CARDEN MA, Brousseau DC, Ahmad FA, Bennett J, et al
    Normal Saline Bolus Use in Pediatric Emergency Departments is Associated with Worse Pain Control in Children with Sickle Cell Anemia and Vaso-occlusive Pain.
    Am J Hematol. 2019 Mar 27. doi: 10.1002/ajh.25471.
    PubMed     Text format     Abstract available


  34. JORDAN LC, Juttukonda MR, Kassim AA, DeBaun MR, et al
    Haploidentical bone marrow transplantation improves cerebral hemodynamics in adults with sickle cell disease.
    Am J Hematol. 2019 Mar 5. doi: 10.1002/ajh.25455.
    PubMed     Text format    


  35. VERCELLOTTI GM, Dalmasso AP, Schaid TR Jr, Nguyen J, et al
    Critical role of C5a in sickle cell disease.
    Am J Hematol. 2019;94:327-337.
    PubMed     Text format     Abstract available


  36. CASALE M, Filosa A, Ragozzino A, Amendola G, et al
    Long-term improvement in cardiac magnetic resonance in beta-thalassemia major patients treated with deferasirox extends to patients with abnormal baseline cardiac function.
    Am J Hematol. 2019;94:312-318.
    PubMed     Text format     Abstract available


  37. RODGERS GM, Kurtti AL, Gilreath JA
    Are eltrombopag plasma and skin hyperpigmentation related? The eyes have it.
    Am J Hematol. 2019;94:394-395.
    PubMed     Text format    


    February 2019
  38. LEAF RK, Ferreri C, Rangachari D, Mier J, et al
    Clinical and Laboratory Features of Autoimmune Hemolytic Anemia Associated with Immune Checkpoint Inhibitors.
    Am J Hematol. 2019 Feb 20. doi: 10.1002/ajh.25448.
    PubMed     Text format     Abstract available


  39. STEWART JT, Willen SM, Cohen R, Rodeghier M, et al
    BMI percentile is an independent predictor of increase in lung function in children with sickle cell anemia.
    Am J Hematol. 2019 Feb 7. doi: 10.1002/ajh.25433.
    PubMed     Text format    


  40. MARSHALL AL, Mann S, Wolanskyj-Spinner A
    Digital storytelling for hematology education: Interactive thalassemia module for graduate millennial learners.
    Am J Hematol. 2019;94:E66-E67.
    PubMed     Text format    


  41. DESAI PC, Kendel N, Huang Y, Heinlein M, et al
    Hypoxia in sickle cell disease due to right to left shunting.
    Am J Hematol. 2019;94:E53-E55.
    PubMed     Text format    


  42. OPPONG SA, Asare EV, Olayemi E, Boafor T, et al
    Multidisciplinary care results in similar maternal and perinatal mortality rates for women with and without SCD in a low-resource setting.
    Am J Hematol. 2019;94:223-230.
    PubMed     Text format     Abstract available


  43. GURUPRASAD P, Mannino RG, Caruso C, Zhang H, et al
    Integrated automated particle tracking microfluidic enables high-throughput cell deformability cytometry for red cell disorders.
    Am J Hematol. 2019;94:189-199.
    PubMed     Text format     Abstract available


  44. EISENGA MF, Wouters HJCM, Kieneker LM, van der Klauw MM, et al
    Active smoking and macrocytosis in the general population: Two population-based cohort studies.
    Am J Hematol. 2019;94:E45-E48.
    PubMed     Text format    


  45. TAHER A, Viprakasit V, Cappellini MD, Sutcharitchan P, et al
    Development of a patient-reported outcomes symptom measure for patients with nontransfusion-dependent thalassemia (NTDT-PRO((c)) ).
    Am J Hematol. 2019;94:171-176.
    PubMed     Text format     Abstract available


  46. SHARARA AI, Rustom LBO, Marrache M, Rimmani HH, et al
    Sofosbuvir/velpatasvir for chronic hepatitis C infection in patients with transfusion-dependent thalassemia.
    Am J Hematol. 2019;94:E43-E45.
    PubMed     Text format    


  47. TAHER A, Cappellini MD, Viprakasit V, Sutcharitchan P, et al
    Validation of a patient-reported outcomes symptom measure for patients with nontransfusion-dependent thalassemia (NTDT-PRO((c)) ).
    Am J Hematol. 2019;94:177-183.
    PubMed     Text format     Abstract available


    January 2019
  48. JIE Z, Jie M, Run-Hui W, Xue Z, et al
    Unusual presentations of sitosterolemia limited to hematological abnormalities: A report of 4 cases presenting with stomatocytic anemia and thrombocytopenia with macrothrombocytes.
    Am J Hematol. 2019 Jan 29. doi: 10.1002/ajh.25427.
    PubMed     Text format    


  49. AKINGBOLA TS, Tayo BO, Ezekekwu CA, Sonubi O, et al
    "Maximum Tolerated Dose" versus "Fixed Low-Dose" Hydroxyurea for Treatment of Adults with Sickle Cell Anemia.
    Am J Hematol. 2019 Jan 21. doi: 10.1002/ajh.25412.
    PubMed     Text format    


  50. OZCAN A, Saracoglu S, Verboon J, Karakukcu M, et al
    A mummy emerges from the grave: Scurvy confounding the clinical presentation of a child with Fanconi Anemia.
    Am J Hematol. 2019 Jan 13. doi: 10.1002/ajh.25402.
    PubMed     Text format    


  51. KRISHNAMURTI L, Neuberg DS, Sullivan KM, Kamani NR, et al
    Bone Marrow Transplantation for Adolescents and Young Adults with Sickle Cell Disease: Results of a Prospective Multicenter Pilot Study.
    Am J Hematol. 2019 Jan 13. doi: 10.1002/ajh.25401.
    PubMed     Text format     Abstract available


  52. PATNAIK MM, Tefferi A
    Refractory Anemia with Ring Sideroblasts (RARS) and RARS with Thrombocytosis (RARS-T) - "2019 Update on Diagnosis, Risk-stratification, and Management".
    Am J Hematol. 2019 Jan 7. doi: 10.1002/ajh.25397.
    PubMed     Text format     Abstract available


  53. BACIGALUPO A, Oneto R, Schrezenmeier H, Hochsmann B, et al
    First line treatment of aplastic anemia with thymoglobuline in Europe and Asia: Outcome of 955 patients treated 2001-2012.
    Am J Hematol. 2019;94:165.
    PubMed     Text format    


  54. BIANCHI P, Fermo E, Glader B, Kanno H, et al
    Addressing the diagnostic gaps in pyruvate kinase deficiency: Consensus recommendations on the diagnosis of pyruvate kinase deficiency.
    Am J Hematol. 2019;94:149-161.
    PubMed     Text format     Abstract available


  55. HAN J, Saraf SL, Molokie RE, Gordeuk VR, et al
    Use of metformin in patients with sickle cell disease.
    Am J Hematol. 2019;94:E13-E15.
    PubMed     Text format    


  56. HAN J, Saraf SL, Gowhari M, Jain S, et al
    High inpatient dose of opioid at discharge compared to home dose predicts readmission risk in sickle cell disease.
    Am J Hematol. 2019;94:E5-E7.
    PubMed     Text format    


  57. CHAPMAN MS, Kiritkumar K, Lund K, Bain BJ, et al
    An unusual hemoglobinopathy: compound heterozygosity for hemoglobins C and E.
    Am J Hematol. 2019;94:144.
    PubMed     Text format    


  58. KUTLAR A, Kanter J, Liles DK, Alvarez OA, et al
    Effect of crizanlizumab on pain crises in subgroups of patients with sickle cell disease: A SUSTAIN study analysis.
    Am J Hematol. 2019;94:55-61.
    PubMed     Text format     Abstract available


  59. STEELE C, Sinski A, Asibey J, Hardy-Dessources MD, et al
    Point-of-care screening for sickle cell disease in low-resource settings: A multi-center evaluation of HemoTypeSC, a novel rapid test.
    Am J Hematol. 2019;94:39-45.
    PubMed     Text format     Abstract available


    December 2018
  60. SHET AS, Mendelsohn L, Harper J, Ostrowski D, et al
    Voxelotor Treatment of a Patient With Sickle Cell Disease and Very Severe Anemia.
    Am J Hematol. 2018 Dec 27. doi: 10.1002/ajh.25389.
    PubMed     Text format    


  61. ARIGLIANI M, Dogara LG, Zubair R, Castriotta L, et al
    Lung function impairment in pediatric patients with sickle cell anemia from Nigeria is associated with low steady state hemoglobin.
    Am J Hematol. 2018 Dec 8. doi: 10.1002/ajh.25373.
    PubMed     Text format    


    November 2018
  62. WANG CY, Canali S, Bayer A, Dev S, et al
    Iron, erythropoietin, and inflammation regulate hepcidin in Bmp2-deficient mice, but serum iron fails to induce hepcidin in Bmp6-deficient mice.
    Am J Hematol. 2018 Nov 27. doi: 10.1002/ajh.25366.
    PubMed     Text format     Abstract available


  63. CHATURVEDI S, Koo M, Dackiw L, Koo G, et al
    Preoperative Treatment of Anemia and Outcomes in Surgical Jehovah's Witness Patients.
    Am J Hematol. 2018 Nov 25. doi: 10.1002/ajh.25359.
    PubMed     Text format    


    October 2018
  64. LEE JW, Peffault de Latour R, Brodsky RA, Jang JH, et al
    Effectiveness of Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) With or Without Aplastic Anemia in the International PNH Registry.
    Am J Hematol. 2018 Oct 29. doi: 10.1002/ajh.25334.
    PubMed     Text format    


  65. ZAHR RS, Hankins JS, Kang G, Li C, et al
    Hydroxyurea prevents onset and progression of albuminuria in children with sickle cell anemia.
    Am J Hematol. 2018 Oct 25. doi: 10.1002/ajh.25329.
    PubMed     Text format    


  66. AUSTIN A, Lund K, Bain BJ
    Striking dyserythropoiesis in sickle cell anemia following an aplastic crisis.
    Am J Hematol. 2018 Oct 25. doi: 10.1002/ajh.25324.
    PubMed     Text format    


  67. SAMARASINGHE S, Clesham K, Iacobelli S, Sbianchi G, et al
    IMPACT OF T-CELL DEPLETION STRATEGIES ON OUTCOMES FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR IDIOPATHIC APLASTIC ANEMIA: A STUDY ON BEHALF OF THE EUROPEAN BLOOD AND MARROW TRANSPLANT (EBMT) SAA WORKING PARTY.
    Am J Hematol. 2018 Oct 17. doi: 10.1002/ajh.25314.
    PubMed     Text format     Abstract available


  68. PRYCE A, Lund K, Shah M, Bain BJ, et al
    Pertussis - an uncommon cause of microangiopathic hemolytic anemia in an infant.
    Am J Hematol. 2018 Oct 17. doi: 10.1002/ajh.25315.
    PubMed     Text format    


    September 2018
  69. DARBARI DS, Eigbire-Molen O, Ponisio MR, Milchenko MV, et al
    Progressive Loss of Brain Volume in Children with Sickle Cell Anemia and Silent Cerebral Infarct: A Report from the Silent Cerebral Infarct Transfusion (SIT) Trial.
    Am J Hematol. 2018 Sep 28. doi: 10.1002/ajh.25297.
    PubMed     Text format    


  70. EGBERG MD, Mitchell PD, Galanko JP, Rufo PA, et al
    Effectiveness of Oral Iron Supplementation in Treatment of Anemia Associated with Pediatric Ulcerative Colitis Flare.
    Am J Hematol. 2018 Sep 28. doi: 10.1002/ajh.25299.
    PubMed     Text format    


  71. DI M, Bian J, Butera JN
    A new onset of thrombocytopenia and microangiopathic hemolytic anemia in the healthcare setting: A challenge for diagnosis.
    Am J Hematol. 2018 Sep 28. doi: 10.1002/ajh.25298.
    PubMed     Text format     Abstract available


  72. BENEDUCE E, Matte A, De Falco L, Mbiandjeu S, et al
    FYN KYNASE IS A NOVEL MODULATOR OF ERYTHROPOIETIN SIGNALING AND STRESS ERYTHROPOIESIS.
    Am J Hematol. 2018 Sep 25. doi: 10.1002/ajh.25295.
    PubMed     Text format     Abstract available


    August 2018
  73. BROUSSE V, El Hoss S, Bouazza N, Arnaud C, et al
    Prognostic factors of disease severity in infants with sickle cell anemia: A comprehensive longitudinal cohort study.
    Am J Hematol. 2018 Aug 21. doi: 10.1002/ajh.25260.
    PubMed     Text format     Abstract available


  74. LEE SE, Park SS, Jeon YW, Yoon JH, et al
    Optimal conditioning regimen for haplo-identical stem cell transplantation in adult patients with acquired severe aplastic anemia: Prospective de-escalation study of TBI and ATG dose.
    Am J Hematol. 2018 Aug 17. doi: 10.1002/ajh.25257.
    PubMed     Text format     Abstract available


  75. VAN STRAATEN S, Biemond BJ, Kerkhoffs JL, Gitz-Francois J, et al
    Iron overload in patients with rare hereditary hemolytic anemia: evidence based suggestion on whom and how to screen.
    Am J Hematol. 2018 Aug 13. doi: 10.1002/ajh.25251.
    PubMed     Text format    


    July 2018
  76. HANINA S, Bain BJ, Clark B, Layton DM, et al
    Congenital sideroblastic anemia in a female.
    Am J Hematol. 2018 Jul 24. doi: 10.1002/ajh.25196.
    PubMed     Text format    


  77. SARNA K, Gebremedin A, Brittenham GM, Beall CM, et al
    WHO hemoglobin thresholds for altitude increase the prevalence of anemia among Ethiopian highlanders.
    Am J Hematol. 2018 Jul 24. doi: 10.1002/ajh.25194.
    PubMed     Text format    


  78. SHANDER A, Goodnough LT
    Management of anemia in patients who decline blood transfusion.
    Am J Hematol. 2018 Jul 22. doi: 10.1002/ajh.25167.
    PubMed     Text format    


  79. STRAUSS WE, Adkinson NF, Macdougall IC, Auerbach M, et al
    A response by Strauss et al. to "A comment on the comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia".
    Am J Hematol. 2018 Jul 17. doi: 10.1002/ajh.25200.
    PubMed     Text format    


  80. BARCELLINI W, Zaninoni A, Fattizzo B, Giannotta JA, et al
    Predictors of refractoriness to therapy and healthcare resource utilization in 378 patients with primary autoimmune hemolytic anemia from 8 Italian Reference Centers.
    Am J Hematol. 2018 Jul 7. doi: 10.1002/ajh.25212.
    PubMed     Text format    


  81. MUNDY LM, Wohlfeil S
    A comment on the comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia.
    Am J Hematol. 2018 Jul 7. doi: 10.1002/ajh.25204.
    PubMed     Text format    


    June 2018
  82. PALMBLAD J, Sander B, Bain B, Klimkowska M, et al
    Congenital dyserythropoietic anemia type 1: a case with novel compound heterozygous mutations in the C15orf41 gene.
    Am J Hematol. 2018 Jun 8. doi: 10.1002/ajh.25157.
    PubMed     Text format    


  83. GANSNER JM, Furutani E, Campagna DR, Fleming MD, et al
    Pancreatic lipomatosis in Diamond-Blackfan anemia: The importance of genetic testing in bone marrow failure disorders.
    Am J Hematol. 2018 Jun 8. doi: 10.1002/ajh.25155.
    PubMed     Text format    


    May 2018
  84. TAYO BO, Akingbola TS, Saraf SL, Shah BN, et al
    Fixed Low-Dose Hydroxyurea for the Treatment of Adults with Sickle Cell Anemia in Nigeria.
    Am J Hematol. 2018 May 14. doi: 10.1002/ajh.25143.
    PubMed     Text format    


    April 2018
  85. ROY S, Rai P, Eiymo Mwa Mpollo MS, Chang KH, et al
    Angiotensin Receptor Signaling in Sickle Cell Anemia has a Reno-Protective effect on Urine Concentrating Ability but results in Sickle Glomerulopathy.
    Am J Hematol. 2018 Apr 20. doi: 10.1002/ajh.25118.
    PubMed     Text format    


  86. PENNA D, Nicolosi M, Vallapureddy RR, Szuber N, et al
    The impact of sex on disease phenotype and prognostic thresholds of anemia in myelodysplastic syndromes.
    Am J Hematol. 2018 Apr 16. doi: 10.1002/ajh.25114.
    PubMed     Text format    


    March 2018
  87. PERGOLA PE, Fishbane S, LeWinter RD, Neylan JF, et al
    Hemoglobin response to ferric citrate in patients with nondialysis-dependent chronic kidney disease and iron deficiency anemia.
    Am J Hematol. 2018 Mar 25. doi: 10.1002/ajh.25088.
    PubMed     Text format    


  88. DERMAN R, Roman E, Smith-Nguyen GN, Achebe MM, et al
    Iron isomaltoside is superior to iron sucrose in increasing hemoglobin in gynecological patients with iron deficiency anemia.
    Am J Hematol. 2018 Mar 23. doi: 10.1002/ajh.25094.
    PubMed     Text format    


  89. JORDAN LC, Williams DOR, Rodeghier MJ, Covert B, et al
    Children with sickle cell anemia with normal TCD and without silent infarcts have a low incidence of new strokes.
    Am J Hematol. 2018 Mar 9. doi: 10.1002/ajh.25085.
    PubMed     Text format     Abstract available


  90. BACIGALUPO A, Oneto R, Schrezenmeier H, Hochsmann B, et al
    First line treatment of aplastic anemia with thymoglobuline in europe and asia: Outcome of 955 patients treated 2001-2012.
    Am J Hematol. 2018 Mar 2. doi: 10.1002/ajh.25081.
    PubMed     Text format     Abstract available


  91. SCHMIDT PJ, Liu K, Visner G, Fitzgerald K, et al
    RNAi-mediated reduction of hepatic Tmprss6 diminishes anemia and secondary iron overload in a splenectomized mouse model of beta-thalassemia intermedia.
    Am J Hematol. 2018 Mar 2. doi: 10.1002/ajh.25079.
    PubMed     Text format     Abstract available


  92. GALADANCI NA, Umar Abdullahi S, Vance LD, Musa Tabari A, et al
    Feasibility trial for primary stroke prevention in children with sickle cell anemia in Nigeria (SPIN trial).
    Am J Hematol. 2018;93:E83.
    PubMed     Text format    


    February 2018
  93. ADKINSON NF, Strauss WE, Macdougall IC, Bernard KE, et al
    Comparative safety of intravenous ferumoxytol vs ferric carboxymaltose in iron deficiency anemia: A randomized trial.
    Am J Hematol. 2018 Feb 8. doi: 10.1002/ajh.25060.
    PubMed     Text format     Abstract available


  94. ASSI R, Kantarjian HM, Garcia-Manero G, Cortes JE, et al
    A phase II trial of ruxolitinib in combination with azacytidine in myelodysplastic syndrome/myeloproliferative neoplasms.
    Am J Hematol. 2018;93:277-285.
    PubMed     Text format     Abstract available


  95. JEREBTSOVA M, Saraf SL, Lin X, Lee G, et al
    Identification of ceruloplasmin as a biomarker of chronic kidney disease in urine of sickle cell disease patients by proteomic analysis.
    Am J Hematol. 2018;93:E45-E47.
    PubMed     Text format    


  96. ELALFY MS, Adly A, Awad H, Tarif Salam M, et al
    Safety and efficacy of early start of iron chelation therapy with deferiprone in young children newly diagnosed with transfusion-dependent thalassemia: A randomized controlled trial.
    Am J Hematol. 2018;93:262-268.
    PubMed     Text format     Abstract available


  97. KHAN AB, Kesse-Adu R, Breen C, Murphy PB, et al
    A descriptive study of the characteristics of older adults with sickle cell disease.
    Am J Hematol. 2018;93:E38-E40.
    PubMed     Text format    


  98. TANABE P, Silva S, Bosworth HB, Crawford R, et al
    A randomized controlled trial comparing two vaso-occlusive episode (VOE) protocols in sickle cell disease (SCD).
    Am J Hematol. 2018;93:159-168.
    PubMed     Text format     Abstract available


    January 2018
  99. PEFFAULT DE LATOUR R, Tabrizi R, Marcais A, Leblanc T, et al
    Nationwide Survey on the Use of Horse Antithymocyte Globulins (ATGAM) in Patients with Acquired Aplastic Anemia: A Report on Behalf of the French Reference Center for Aplastic Anemia.
    Am J Hematol. 2018 Jan 27. doi: 10.1002/ajh.25050.
    PubMed     Text format     Abstract available


  100. HERGOTT CB, Pozdnyakova O
    Evans syndrome secondary to undiagnosed chronic lymphocytic leukemia in a patient with unexplained bleeding.
    Am J Hematol. 2018 Jan 17. doi: 10.1002/ajh.25039.
    PubMed     Text format    


  101. JEREBTSOVA M, Saraf SL, Soni S, Afangbedji N, et al
    Urinary Orosomucoid is Associated with Progressive Chronic Kidney Disease Stage in Patients with Sickle Cell Anemia.
    Am J Hematol. 2018 Jan 12. doi: 10.1002/ajh.25036.
    PubMed     Text format    


  102. VANHINSBERGH L, Uthaya S, Bain BJ
    Methylene blue-induced Heinz body hemolytic anemia in a premature neonate.
    Am J Hematol. 2018 Jan 5. doi: 10.1002/ajh.25028.
    PubMed     Text format    


  103. ANDOLFO I, Russo R, Gambale A, Iolascon A, et al
    Hereditary stomatocytosis: An underdiagnosed condition.
    Am J Hematol. 2018;93:107-121.
    PubMed     Text format     Abstract available


  104. BARRETT A, Catherwood M, Thornton P, Murphy P, et al
    Transformation of MDS/MPN-RS-T to AML: Trisomy 13, resistant thrombocytosis and transient disease control with oral busulfan therapy.
    Am J Hematol. 2018;93:E16-E17.
    PubMed     Text format    


  105. NOLAN VG, Anderson SM, Smeltzer MP, Porter JS, et al
    Pediatric to adult care co-location transitional model for youth with sickle cell disease.
    Am J Hematol. 2018;93:E30-E32.
    PubMed     Text format    


  106. NICOLOSI M, Mudireddy M, Vallapureddy R, Gangat N, et al
    Lenalidomide therapy in patients with myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T).
    Am J Hematol. 2018;93:E27-E30.
    PubMed     Text format    


  107. HAN J, Saraf SL, Kavoliunaite L, Jain S, et al
    Program expansion of a day hospital dedicated to manage sickle cell pain.
    Am J Hematol. 2018;93:E20-E21.
    PubMed     Text format    


  108. KAUFMAN HW, Niles JK, Gallagher DR, Rivera A, et al
    Revised prevalence estimate of possible Hereditary Xerocytosis as derived from a large U.S. Laboratory database.
    Am J Hematol. 2018;93:E9-E12.
    PubMed     Text format    


  109. GINWALLA M, AlMasoud A, Tofovic D, Alin T, et al
    Cardiovascular evaluation and management of iron overload cardiomyopathy in sickle cell disease.
    Am J Hematol. 2018;93:E7-E9.
    PubMed     Text format    


    December 2017
  110. FATTIZZO B, Zaninoni A, Gianelli U Prof, Zanella A Prof, et al
    Prognostic impact of bone marrow fibrosis and dyserythropoiesis in autoimmune hemolytic anemia.
    Am J Hematol. 2017 Dec 23. doi: 10.1002/ajh.25020.
    PubMed     Text format    


  111. WILLEN SM, Rodeghier M, Rosen CL, DeBaun MR, et al
    Sleep disordered breathing does not predict acute severe pain episodes in children with sickle cell anemia.
    Am J Hematol. 2017 Dec 20. doi: 10.1002/ajh.25013.
    PubMed     Text format     Abstract available


  112. WILLEN SM, Cohen R, Rodeghier M, Kirkham F, et al
    Age is the only predictor of small decrease in lung function in children with sickle cell anemia.
    Am J Hematol. 2017 Dec 11. doi: 10.1002/ajh.25003.
    PubMed     Text format     Abstract available


  113. DAVIES JOJ, Hart AC, De La Fuente J, Bain BJ, et al
    Macrophage activation syndrome and post-transplant microangiopathy following haploidentical bone marrow transplantation for sickle cell anemia.
    Am J Hematol. 2017 Dec 2. doi: 10.1002/ajh.24995.
    PubMed     Text format    


  114. DE FALCO L, Tortora R, Imperatore N, Bruno M, et al
    The role of tmprss6 and hfe variants in iron deficiency anemia in celiac disease.
    Am J Hematol. 2017 Dec 1. doi: 10.1002/ajh.24991.
    PubMed     Text format     Abstract available


  115. PINTO VM, Gianesin B, Balocco M, Bacigalupo L, et al
    Noninvasive monitoring of liver fibrosis in sickle cell disease: Longitudinal observation of a cohort of adult patients.
    Am J Hematol. 2017;92:E666-E668.
    PubMed     Text format    


  116. TAHER AT, Saliba AN, Kuo KH, Giardina PJ, et al
    Safety and pharmacokinetics of the oral iron chelator SP-420 in beta-thalassemia.
    Am J Hematol. 2017;92:1356-1361.
    PubMed     Text format     Abstract available


  117. NARBEY D, Habibi A, Chadebech P, Mekontso-Dessap A, et al
    Incidence and predictive score for delayed hemolytic transfusion reaction in adult patients with sickle cell disease.
    Am J Hematol. 2017;92:1340-1348.
    PubMed     Text format     Abstract available


  118. SALIBA AN, Moukhadder HM, Harb A, Beydoun H, et al
    Causes of hospital admission in beta-thalassemia (CHAT) in Lebanon from 1995 to 2015: A pilot retrospective study from a tertiary care center.
    Am J Hematol. 2017;92:E652-E653.
    PubMed     Text format    


  119. CAOCCI G, Orofino MG, Vacca A, Piroddi A, et al
    Long-term survival of beta thalassemia major patients treated with hematopoietic stem cell transplantation compared with survival with conventional treatment.
    Am J Hematol. 2017;92:1303-1310.
    PubMed     Text format     Abstract available


  120. WORSHAM CM, Martin ST, Nouraie SM, Cohen RT, et al
    Clinical and laboratory findings associated with sleep disordered breathing in sickle cell disease.
    Am J Hematol. 2017;92:E649-E651.
    PubMed     Text format    


  121. SCHARMAN CD, Burger D, Shatzel JJ, Kim E, et al
    Treatment of individuals who cannot receive blood products for religious or other reasons.
    Am J Hematol. 2017;92:1370-1381.
    PubMed     Text format     Abstract available


    November 2017
  122. CASALE M, Borriello A, Scianguetta S, Roberti D, et al
    Hereditary hypochromic microcytic anemia associated with loss-of-function DMT1 gene mutations and absence of liver iron overload.
    Am J Hematol. 2017 Nov 27. doi: 10.1002/ajh.24988.
    PubMed     Text format    


  123. MACHARIA AW, Mochamah G, Uyoga S, Ndila CM, et al
    The clinical epidemiology of sickle cell anemia in Africa.
    Am J Hematol. 2017 Nov 23. doi: 10.1002/ajh.24986.
    PubMed     Text format     Abstract available


  124. ALTMAN JK, Foran JM, Pratz KW, Trone D, et al
    Phase 1 Study of Quizartinib in Combination With Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia.
    Am J Hematol. 2017 Nov 15. doi: 10.1002/ajh.24974.
    PubMed     Text format     Abstract available


  125. KHALEEL M, Puliyel M, Shah P, Sunwoo J, et al
    Individuals with sickle cell disease have a significantly greater vasoconstriction response to thermal pain than controls and have significant vasoconstriction in response to anticipation of pain.
    Am J Hematol. 2017;92:1137-1145.
    PubMed     Text format     Abstract available


  126. SOLOVEY A, Somani A, Belcher JD, Milbauer L, et al
    A monocyte-TNF-endothelial activation axis in sickle transgenic mice: Therapeutic benefit from TNF blockade.
    Am J Hematol. 2017;92:1119-1130.
    PubMed     Text format     Abstract available


  127. NADER E, Connes P, Lamarre Y, Renoux C, et al
    Plasmapheresis may improve clinical condition in sickle cell disease through its effects on red blood cell rheology.
    Am J Hematol. 2017;92:E629-E630.
    PubMed     Text format    


  128. SCHIMMEL M, Luken BM, Nur E, van Tuijn CFJ, et al
    Inflammatory and endothelial markers during vaso-occlusive crisis and acute chest syndrome in sickle cell disease.
    Am J Hematol. 2017;92:E634-E636.
    PubMed     Text format    


  129. ORIGA R, Tatti F, Zappu A, Leoni GB, et al
    Earlier initiation of transfusional and iron chelation therapies in recently born children with transfusion-dependent thalassemia.
    Am J Hematol. 2017;92:E627-E628.
    PubMed     Text format    


    October 2017
  130. GONZALES GF, Rubin de Celis V, Begazo J, Hinojosa MDR, et al
    Correcting the cut-off point of hemoglobin at high altitude favors misclassification of anemia, erythrocytosis and excessive erythrocytosis.
    Am J Hematol. 2017 Oct 6. doi: 10.1002/ajh.24932.
    PubMed     Text format    


  131. MARTINEZ C, Watson DJ, Shebl A, Wallenhorst C, et al
    Impact of screening and exclusion of high anti-A titer donors on the risk of hemolytic anemia with intravenous immunoglobulin treatment - a hospital-based cohort study in the US.
    Am J Hematol. 2017 Oct 6. doi: 10.1002/ajh.24931.
    PubMed     Text format    


  132. VAN TUIJN CFJ, Schimmel M, van Beers EJ, Nur E, et al
    Prospective evaluation of chronic organ damage in adult sickle cell patients: A seven-year follow-up study.
    Am J Hematol. 2017;92:E584-E590.
    PubMed     Text format     Abstract available


  133. SUN CW, Wu LC, Knopick PL, Bradley DS, et al
    Sickle cells produce functional immune modulators and cytotoxics.
    Am J Hematol. 2017;92:981-988.
    PubMed     Text format     Abstract available


  134. CAPPELLINI MD, Comin-Colet J, de Francisco A, Dignass A, et al
    Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management.
    Am J Hematol. 2017;92:1068-1078.
    PubMed     Text format     Abstract available


  135. WAHIDIYAT PA, Sekarsari D, Adnani NB, Putriasih SA, et al
    Association of pancreatic MRI R2* with blood glucose and cardiac MRI R2* among thalassemia major patients in Indonesia.
    Am J Hematol. 2017;92:E620-E621.
    PubMed     Text format    


  136. AL-RIYAMI AZ, Iolascon A, Al-Zadjali S, Andolfo I, et al
    Targeted next generation sequencing identifies a novel beta-spectrin gene mutation A2059P in two Omani children with hereditary pyropoikilocytosis.
    Am J Hematol. 2017;92:E607-E609.
    PubMed     Text format    


    September 2017
  137. ESTEPP JH, Smeltzer MP, Kang G, Li C, et al
    A Clinically Meaningful Fetal Hemoglobin Threshold for Children with Sickle Cell Anemia During Hydroxyurea Therapy.
    Am J Hematol. 2017 Sep 14. doi: 10.1002/ajh.24906.
    PubMed     Text format     Abstract available


  138. ASARE EV, Olayemi E, Boafor T, Dei-Adomakoh Y, et al
    Implementation of multidisciplinary care reduces maternal mortality in women with sickle cell disease living in low-resource setting.
    Am J Hematol. 2017;92:872-878.
    PubMed     Text format     Abstract available


  139. BIALKOWSKI W, Kiss JE, Wright DJ, Cable R, et al
    Estimates of total body iron indicate 19 mg and 38 mg oral iron are equivalent for the mitigation of iron deficiency in individuals experiencing repeated phlebotomy.
    Am J Hematol. 2017;92:851-857.
    PubMed     Text format     Abstract available


  140. BARSHTEIN G, Goldschmidt N, Pries AR, Zelig O, et al
    Deformability of transfused red blood cells is a potent effector of transfusion-induced hemoglobin increment: A study with beta-thalassemia major patients.
    Am J Hematol. 2017;92:E559-E560.
    PubMed     Text format    


  141. SOOD R, Jiramongkolchai K, Streiff M, Gonzalez C, et al
    Look into my eyes: An unusual first presentation of sickle cell disease.
    Am J Hematol. 2017;92:968-971.
    PubMed     Text format    


  142. SIOW W, Matthey F, Bain BJ
    The significance of irregularly contracted cells and hemighosts in sickle cell disease.
    Am J Hematol. 2017;92:966-967.
    PubMed     Text format    


    August 2017
  143. BODDU P, Garcia-Manero G, Ravandi F, Borthakur G, et al
    Clinical Outcomes in Adult Patients with Aplastic Anemia- a single institution experience.
    Am J Hematol. 2017 Aug 29. doi: 10.1002/ajh.24897.
    PubMed     Text format     Abstract available


    July 2017
  144. ALVAREZ O, Nottage K, Simpson LM, Wood J, et al
    Kidney Function of Transfused Children with Sickle Cell Anemia: Baseline Data from the TWiTCH Study with Comparison to Non-Transfused Cohorts.
    Am J Hematol. 2017 Jul 25. doi: 10.1002/ajh.24871.
    PubMed     Text format    


  145. HABARA AH, Shaikho EM, Steinberg MH
    Fetal Hemoglobin in Sickle Cell Anemia: The Arab-Indian Haplotype and New Therapeutic Agents.
    Am J Hematol. 2017 Jul 24. doi: 10.1002/ajh.24872.
    PubMed     Text format     Abstract available


  146. WITZIG TE, Zinzani PL, Habermann TM, Tuscano JM, et al
    Long-Term Analysis of Phase II Studies of Single-Agent Lenalidomide in Relapsed/Refractory Mantle Cell Lymphoma.
    Am J Hematol. 2017 Jul 11. doi: 10.1002/ajh.24854.
    PubMed     Text format     Abstract available


  147. YEE MEM, Lane PA, Archer DR, Joiner CH, et al
    Estimation of Glomerular Filtration Rate Using Serum Cystatin C and Creatinine in Adults with Sickle Cell Anemia.
    Am J Hematol. 2017 Jul 3. doi: 10.1002/ajh.24840.
    PubMed     Text format    


  148. GLASSBERG J, Minnitti C, Cromwell C, Cytryn L, et al
    Inhaled steroids reduce pain and sVCAM levels in individuals with sickle cell disease: A triple-blind, randomized trial.
    Am J Hematol. 2017;92:622-631.
    PubMed     Text format     Abstract available


    June 2017
  149. VASSEUR C, Domingues-Hamdi E, Pakdaman S, Barau C, et al
    Elevated soluble alpha-hemoglobin pool in Sickle Cell Anemia.
    Am J Hematol. 2017 Jun 24. doi: 10.1002/ajh.24835.
    PubMed     Text format    


  150. KASTHURI RS, Montifar M, Nelson J, Kim H, et al
    Prevalence and Predictors of Anemia in Hereditary Hemorrhagic Telangiectasia.
    Am J Hematol. 2017 Jun 22. doi: 10.1002/ajh.24832.
    PubMed     Text format    


  151. SHAIKHO EM, Farrell JJ, Alsultan A, Sebastiani P, et al
    Genetic Determinants of HbF in Saudi Arabian and African Benin Haplotype Sickle Cell Anemia.
    Am J Hematol. 2017 Jun 13. doi: 10.1002/ajh.24822.
    PubMed     Text format    


  152. QUINN CT, Saraf SL, Gordeuk VR, Fitzhugh CD, et al
    Losartan for the Nephropathy of Sickle Cell Anemia: A Phase-2, Multi-Center Trial.
    Am J Hematol. 2017 Jun 7. doi: 10.1002/ajh.24810.
    PubMed     Text format     Abstract available


  153. GOMPERTS E, Belcher JD, Otterbein LE, Coates TD, et al
    The role of carbon monoxide and heme oxygenase in the prevention of sickle cell disease vaso-occlusive crises.
    Am J Hematol. 2017;92:569-582.
    PubMed     Text format     Abstract available


  154. HADJIDEMETRIOU M
    Thalassemia: Yesterday, Today, Tomorrow.
    Am J Hematol. 2017;92:490-492.
    PubMed     Text format    


  155. BALDINI M, Mancarella M, Cassinerio E, Marcon A, et al
    Adrenal insufficiency: An emerging challenge in thalassemia?
    Am J Hematol. 2017;92:E119-E121.
    PubMed     Text format    


  156. BRENNAN Y, Curnow J, Favaloro EJ
    2B or not 2B? A prothrombotic tendency masquerading as a bleeding disorder.
    Am J Hematol. 2017;92:584-590.
    PubMed     Text format    


  157. ANDERSON N, Eckman JR, Ballas SK
    Beyond the transition of adolescents and young adults with sickle cell disease to adult care: Role of geography.
    Am J Hematol. 2017;92:E110-E112.
    PubMed     Text format    


  158. RIVERA A, Vandorpe DH, Shmukler BE, Gallagher DR, et al
    Erythrocytes from hereditary xerocytosis patients heterozygous for KCNN4 V282M exhibit increased spontaneous Gardos channel-like activity inhibited by senicapoc.
    Am J Hematol. 2017;92:E108-E110.
    PubMed     Text format    


  159. ROUMI JE, Moukhadder HM, Graziadei G, Pennisi M, et al
    Pregnancy in beta-thalassemia intermedia at two tertiary care centers in Lebanon and Italy: A follow-up report on fetal and maternal outcomes.
    Am J Hematol. 2017;92:E96-E99.
    PubMed     Text format    


  160. LAMBERT MP, Witmer CM, Kwiatkowski JL
    Therapy induced iron deficiency in children treated with eltrombopag for immune thrombocytopenia.
    Am J Hematol. 2017;92:E88-E91.
    PubMed     Text format    


  161. MINNITI CP, Vichinsky E
    Lifespan care in SCD: Whom to transition, the patients or the health care system?
    Am J Hematol. 2017;92:487-489.
    PubMed     Text format    


    May 2017
  162. HANSEN BR, Bottner WA, Ravindran A, DeJesus R, et al
    A follow-up on Desiderosmia (olfactory craving), a novel symptom associated with iron deficiency anemia.
    Am J Hematol. 2017 May 31. doi: 10.1002/ajh.24806.
    PubMed     Text format    


  163. TAHER AT, Origa R, Perrotta S, Kourakli A, et al
    New film-coated tablet formulation of deferasirox is well tolerated in patients with thalassemia or lower-risk MDS: Results of the randomized, phase II ECLIPSE study.
    Am J Hematol. 2017;92:420-428.
    PubMed     Text format     Abstract available


  164. HALAWI R, Cappellini MD, Taher A
    A higher prevalence of hematologic malignancies in patients with thalassemia: Background and culprits.
    Am J Hematol. 2017;92:414-416.
    PubMed     Text format    


  165. READING NS, Ruiz-Bonilla JA, Christensen RD, Caceres-Perkins W, et al
    A patient with both methemoglobinemia and G6PD deficiency: A therapeutic conundrum.
    Am J Hematol. 2017;92:474-477.
    PubMed     Text format    


  166. HALAWI R, Beydoun H, Cappellini MD, Ferla V, et al
    Hematologic malignancies in thalassemia: Adding new cases to the repertoire.
    Am J Hematol. 2017;92:E68-E70.
    PubMed     Text format    


  167. FURLAN L, Graziadei G, Colombo G, Forzenigo LV, et al
    K. pneumoniae liver abscess following deferoxamine subcutaneous self-injection.
    Am J Hematol. 2017;92:480-481.
    PubMed     Text format    


  168. ANGELUCCI E, Pilo F, Coates TD
    Transplantation in thalassemia: Revisiting the Pesaro risk factors 25 years later.
    Am J Hematol. 2017;92:411-413.
    PubMed     Text format    


    April 2017
  169. GALADANCI N, Abdullahi SU, Vance LD, Tabari AM, et al
    Feasibility Trial for Primary Stroke Prevention in Children with Sickle Cell Anemia in Nigeria (SPIN Trial).
    Am J Hematol. 2017 Apr 25. doi: 10.1002/ajh.24770.
    PubMed     Text format     Abstract available


  170. RAVINDRAN A, Sankaran J, Jacob EK, Kreuter JD, et al
    High prevalence of monoclonal gammopathy among patients with warm autoimmune hemolytic anemia.
    Am J Hematol. 2017 Apr 24. doi: 10.1002/ajh.24765.
    PubMed     Text format    


  171. COURONNE L, Tertian G, Boutron A, Picard V, et al
    A Somatic Mosaicism in the G6PD Gene Inducing a Late Onset Chronic non Spherocytic Hemolytic Anemia.
    Am J Hematol. 2017 Apr 10. doi: 10.1002/ajh.24760.
    PubMed     Text format    


  172. HANSEN JW, Sandholdt H, Siersma V, Orskov AD, et al
    "Anemia is present years before myelodysplastic syndrome diagnosis - results from the pre-diagnostic period".
    Am J Hematol. 2017 Apr 6. doi: 10.1002/ajh.24757.
    PubMed     Text format    


  173. GRALL M, Azoulay E, Galicier L, Provot F, et al
    Thrombotic thrombocytopenic purpura misdiagnosed as autoimmune cytopenia: Causes of diagnostic errors and consequence on outcome. Experience of the French thrombotic microangiopathies reference centre.
    Am J Hematol. 2017;92:381-387.
    PubMed     Text format     Abstract available


  174. LI LY, Liu ZY, Liu H, Liu CY, et al
    Deep sequencing of whole genome exon in paroxysmal nocturnal hemoglobinuria.
    Am J Hematol. 2017;92:E51-E53.
    PubMed     Text format    


  175. STEHOUWER N, Edge P, Katie Park B, Piccone C, et al
    Acute pain in adolescents and young adults with sickle cell disease: Delayed and increased opioid dosing following transition to adult care.
    Am J Hematol. 2017;92:E40-E42.
    PubMed     Text format    


  176. MANU PEREIRA MD, Ropero P, Loureiro C, Vives Corrons JL, et al
    Low affinity hemoglobinopathy (Hb Vigo) due to a new mutation of beta globin gene (c200 A>T; Lys>Ile). A cause of rare anemia misdiagnosis.
    Am J Hematol. 2017;92:E38-E40.
    PubMed     Text format    


    March 2017
  177. NASSIN ML, Vergilio JA, Heeney MM, LaBelle JL, et al
    Neonatal Anemia: Revisiting the Enigmatic Pyknocyte.
    Am J Hematol. 2017 Mar 23. doi: 10.1002/ajh.24731.
    PubMed     Text format    


  178. LEWEN MO, Kavanagh PL, Sobota AE
    A comment on improving transcranial Doppler ultrasonography screening in children with sickle cell anemia.
    Am J Hematol. 2017 Mar 23. doi: 10.1002/ajh.24727.
    PubMed     Text format    


  179. MEKONTSO DESSAP A, Cecchini J, Chaar V, Marcos E, et al
    Telomere attrition in sickle cell anemia.
    Am J Hematol. 2017 Mar 15. doi: 10.1002/ajh.24721.
    PubMed     Text format    


  180. FARRUGGIA P, Puccio G, Ramenghi U, Colombatti R, et al
    Recombinant erythropoietin vs. blood transfusion care in infants with hereditary spherocytosis: A retrospective cohort study of A.I.E.O.P. patients (Associazione Italiana Emato-Oncologia Pediatrica).
    Am J Hematol. 2017 Mar 6. doi: 10.1002/ajh.24713.
    PubMed     Text format    


  181. PATNAIK MM, Tefferi A
    Refractory anemia with ring sideroblasts (RARS) and RARS with thrombocytosis (RARS-T): 2017 update on diagnosis, risk-stratification, and management.
    Am J Hematol. 2017;92:297-310.
    PubMed     Text format     Abstract available


  182. SALIBA AN, Musallam KM, Cappellini MD, Graziadei G, et al
    Serum ferritin values between 300 and 800 ng/mL in nontransfusion-dependent thalassemia: A probability curve to guide clinical decision making when MRI is unavailable.
    Am J Hematol. 2017;92:E35-E37.
    PubMed     Text format    


  183. SCHOTTEN N, Laarakkers CM, Roelofs RW, Origa R, et al
    EPO and hepcidin plasma concentrations in blood donors and beta-thalassemia intermedia are not related to commercially tested plasma ERFE concentrations.
    Am J Hematol. 2017;92:E29-E31.
    PubMed     Text format    


  184. BARCELLINI W, Fattizzo B, Zaninoni A, Valli V, et al
    Clinical evolution of autoimmune cytopenias to idiopathic cytopenias/dysplasias of uncertain significance (ICUS/IDUS) and bone marrow failure syndromes.
    Am J Hematol. 2017;92:E26-E29.
    PubMed     Text format    


  185. GRAFFEO L, Vitrano A, Giambona A, Scondotto S, et al
    The heterozygote state for beta-thalassemia detrimentally affects health outcomes.
    Am J Hematol. 2017;92:E23-E25.
    PubMed     Text format    


  186. SOKOL KA, Veluswamy RR, Zimmerman BS, Tummalapalli SL, et al
    Atypical hemolytic uremic syndrome associated with Capnocytophaga canimorsus.
    Am J Hematol. 2017;92:322.
    PubMed     Text format    


    February 2017
  187. HANSEN BR, Bottner WA, Ravindran A, DeJesus R, et al
    Desiderosmia (olfactory craving): A novel symptom associated with iron deficiency anemia.
    Am J Hematol. 2017 Feb 27. doi: 10.1002/ajh.24706.
    PubMed     Text format    


  188. LEAF RK, O'Brien KL, Leaf DE, Drews RE, et al
    Autoimmune hemolytic anemia in a young man with acute hepatitis E infection.
    Am J Hematol. 2017 Feb 23. doi: 10.1002/ajh.24699.
    PubMed     Text format    


  189. WHIPPLE NS, Schwartz JR, Nottage KA
    DAT-positive Plasmodium ovale malaria presenting in a child with sickle cell anemia.
    Am J Hematol. 2017 Feb 17. doi: 10.1002/ajh.24691.
    PubMed     Text format    


  190. BENNANI NN, LaPlant BR, Ansell SM, Habermann TM, et al
    Efficacy of the oral mTORC1 inhibitor everolimus in relapsed or refractory indolent lymphoma.
    Am J Hematol. 2017 Feb 17. doi: 10.1002/ajh.24671.
    PubMed     Text format     Abstract available


  191. ALELUIA MM, Santiago RP, da Guarda CC, Fonseca TC, et al
    Genetic Modulation of Fetal Hemoglobin in Hydroxyurea-Treated Sickle Cell Anemia.
    Am J Hematol. 2017 Feb 13. doi: 10.1002/ajh.24680.
    PubMed     Text format    


  192. CHATURVEDI S, Labib Ghafuri D, Kassim A, Rodeghier M, et al
    Elevated tricuspid regurgitant jet velocity, reduced forced expiratory volume in 1 second, and mortality in adults with sickle cell disease.
    Am J Hematol. 2017;92:125-130.
    PubMed     Text format     Abstract available


  193. WRAY K, Allen A, Evans E, Fisher C, et al
    Hepcidin detects iron deficiency in Sri Lankan adolescents with a high burden of hemoglobinopathy: A diagnostic test accuracy study.
    Am J Hematol. 2017;92:196-203.
    PubMed     Text format     Abstract available


  194. VAN TUIJN CF, Sins JW, Fijnvandraat K, Biemond BJ, et al
    Daily pain in adults with sickle cell disease-a different perspective.
    Am J Hematol. 2017;92:179-186.
    PubMed     Text format     Abstract available


  195. DELVILLE M, Manceau S, Ait Abdallah N, Stolba J, et al
    Arterio-venous fistula for automated red blood cells exchange in patients with sickle cell disease: Complications and outcomes.
    Am J Hematol. 2017;92:136-140.
    PubMed     Text format     Abstract available


    January 2017
  196. DERMAN R, Roman E, Modiano MR, Okam MM, et al
    A randomized trial of iron isomaltoside versus iron sucrose in patients with iron deficiency anemia.
    Am J Hematol. 2017 Jan 4. doi: 10.1002/ajh.24633.
    PubMed     Text format     Abstract available


  197. DAI Y, Sangerman J, Nouraie M, Faller AD, et al
    Effects of hydroxyurea on F-cells in sickle cell disease and potential impact of a second fetal globin inducer.
    Am J Hematol. 2017;92:E10-E11.
    PubMed     Text format    


    December 2016
  198. JACOB SA, Novelli EM, Isenberg JS, Garrett ME, et al
    Thrombospondin-1 Gene Polymorphism is Associated with Estimated Pulmonary Artery Pressure in Patients with Sickle Cell Anemia.
    Am J Hematol. 2016 Dec 29. doi: 10.1002/ajh.24635.
    PubMed     Text format    


  199. RICCHI P, Costantini S, Spasiano A, Di Matola T, et al
    Myelolipoma among patients with thalassemia major and rare anemia with iron loading: A not so rare entity.
    Am J Hematol. 2016 Dec 22. doi: 10.1002/ajh.24622.
    PubMed     Text format    


  200. BAIN BJ
    Howell-Jolly bodies in acute hemolytic anemia.
    Am J Hematol. 2016 Dec 22. doi: 10.1002/ajh.24624.
    PubMed     Text format    


    October 2016
  201. GOODNOUGH LT, Comin-Colet J, Leal-Noval S, Ozawa S, et al
    Management of Anemia in Patients with Congestive Heart Failure.
    Am J Hematol. 2016 Oct 25. doi: 10.1002/ajh.24595.
    PubMed     Text format     Abstract available


  202. QUARMYNE MO, Dong W, Theodore R, Anand S, et al
    Hydroxyurea Effectiveness in Children and Adolescents with Sickle Cell Anemia: A Large Retrospective, Population-Based Cohort.
    Am J Hematol. 2016 Oct 19. doi: 10.1002/ajh.24587.
    PubMed     Text format     Abstract available


  203. MICHEL M, Terriou L, Roudot-Thoraval F, Hamidou M, et al
    A Randomized and Double-Blind Controlled Trial Evaluating the Safety and Efficacy of Rituximab for Warm Auto-Immune Hemolytic Anemia in Adults (the RAIHA study).
    Am J Hematol. 2016 Oct 3. doi: 10.1002/ajh.24570.
    PubMed     Text format     Abstract available


    September 2016
  204. QUINN CT, Smith EP, Arbabi S, Khera PK, et al
    Biochemical surrogate markers of hemolysis do not correlate with directly measured erythrocyte survival in sickle cell anemia.
    Am J Hematol. 2016 Sep 20. doi: 10.1002/ajh.24562.
    PubMed     Text format     Abstract available


  205. DONKER AE, Schaap CC, Novotny VM, Smeets R, et al
    Iron Refractory Iron Deficiency Anemia (IRIDA): A heterogeneous disease that is not always iron refractory.
    Am J Hematol. 2016 Sep 19. doi: 10.1002/ajh.24561.
    PubMed     Text format     Abstract available


  206. DEITERING S, Anslemo L, Burnett A, Jakeman B, et al
    Safety and effectiveness of extended versus shortened iron dextran infusion time for the treatment of iron deficiency anemia.
    Am J Hematol. 2016 Sep 15. doi: 10.1002/ajh.24555.
    PubMed     Text format    


    May 2016
  207. KROPSHOFER G, Sopper S, Steurer M, Schwinger W, et al
    Successful management of mixed chimerism after bone marrow transplant in beta-thalassemia major.
    Am J Hematol. 2016 May 30. doi: 10.1002/ajh.24436.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Anemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: